Research

NeuroEndocrine Cancer Australia is governed by five pillars: patient support, education, research, awareness and advocacy.

These pillars have been created to give neuroendocrine cancer patients, their families and friends, a voice in the community and access to the care and treatment that they deserve.

As Australia’s only not for profit providing support to patients living with NETs we strive to support NET research and clinical trials within Australia and around the world.

Below are some of the ways our services and funding contributes to NET research.

Filter by:
Or browse by
popular tag:

New discovery for pancreatic neuroendocrine tumors (pNETS)

Breaking down the breakthroughs with Prof Anthony Gill AM

Study shows immunotherapy combination shrinks rare NET cancer

NET Registry and Patient App starts rollout

Promising results from Phase II clinical trial

Peter MacCallum Centre of Excellence in Cellular Immunotherapy

NETRF announces US$2.5 million in research funds

Breakthrough from Weill Cornell Medicine

INCA poster wins “Best Poster” at ESMO in Munich

Great news – extension of Clinical Trial

National Oncology Alliance (NOA) wants more subsidies for rare cancers

$10 million funding for rare cancers

Neuroendocrine Cancer Day

Neuroendocrine Cancer Day is on 10 November, and every bit of support counts.

Create an event, share your artwork, or donate on our ‘Double Your Impact’ days. There are so many ways to stand with the NET community.